Approvals and indications of this drug were based on 3 main clinical trials.
Jola Mehmeti, PharmD, MBA
Advertisement
Jola Mehmeti is a 2018 PharmD graduate from the UConn School of Pharmacy. She is a PGY1 Clinical Research Pharmacy Resident at Michigan Medicine. Connect with her on LinkedIn or send a message to [email protected].
Articles by Jola Mehmeti, PharmD, MBA
Studying for the MPJE can be daunting. Numerous online threads offer advice on where to start
Food allergens can be present in a variety of medications, but they don't always merit a switch in therapy.
Advertisement
Latest Updated Articles
- A Quick Overview of CDK4/6 Inhibitor Palbociclib
July 12th 2018
- Five Food Allergens Pharmacists Should Know
June 27th 2018
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
2
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
3
Montelukast Prophylaxis Reduces Rituximab Infusion Reactions in Oncology Patients
4
Afami-cel Receives Full FDA Approval, Expanded Indication to Treat Pediatric Patients With Synovial Sarcoma
5